F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma-Reference-Cited by-同舟云学术

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma

Published:2014-03-15 Issue:6 Volume:165 Page:793-800
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Gentzler Ryan D.¹,Evens Andrew M.²,Rademaker Alfred W.³,Weitner Bing B.³,Mittal Bharat B.⁴,Dillehay Gary L.⁵,Petrich Adam M.¹,Altman Jessica K.¹,Frankfurt Olga¹,Variakojis Daina⁶,Singhal Seema¹,Mehta Jayesh¹,Williams Stephanie⁷,Kaminer Lynne⁸,Gordon Leo I.¹,Winter Jane N.¹

Affiliation:

1. Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL USA

2. Division of Hematology/Oncology; The University of Massachusetts Medical School; Worcester MA USA

3. Department of Preventive Medicine and the Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL USA

4. Department of Radiation Oncology and the Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL USA

5. Department of Radiology and the Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL USA

6. Department of Pathology and the Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine; Chicago IL USA

7. Spectrum Health Medical Group; Adult Blood and Marrow Transplant Program; Grand Rapids MI USA

8. NorthShore Medical Group; Evanston IL USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12824/fullpdf

Reference32 articles.

1. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma;Barrington;European Journal of Nuclear Medicine and Molecular Imaging,2010

2. Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients;Czyz;Annals of Oncology,2004

3. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study;Engert;Journal of Clinical Oncology,2009

4. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma;Engert;New England Journal of Medicine,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the best salvage therapy for Hodgkin lymphoma?;Current Opinion in Oncology;2024-06-20

2. Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi;International Journal of Radiation Oncology*Biology*Physics;2023-08

3. Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma;JAMA Oncology;2023-05-01

4. Do all patients with primary refractory/first relapse of HL need autologous stem cell transplant?;Hematology;2022-12-09

5. Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE;Blood;2022-06-23